Henry Kay

  • Henry Kay is the U.S. Partner of Medica Venture Partners, a healthcare dedicated VC based in Israel and is an active member of two Angel Investing Groups ( Boston Harbor Angels and Launchpad).

    He retired from Boston Scientific in 2006, where he was Group Vice President of New Market Development / Strategic Planning, Endosurgery Boston Scientific Corporation (BSC).

    Prior to joining BSC, Henry was based in the UK for five years as Senior Vice President, Sales and Marketing for Allergan Europe, a global eye care company

    He has 35 years of experience in the medical industry in roles which include R&D, International Marketing, Regulatory Affairs, and Strategic Planning for major pharmaceutical companies, including Schering-Plough and American Home Products.

    Henry is a fellow of the Royal Society of Medicine (UK). He serves on the Boards of several start up health care companies, including Smart Cells (sold to Merck in 2006), Cool Systems, Wadsworth Medical, and Cannuflow. He was a member of the board of Directors of Microfluidics, a public company in the equipment space for pharmaceutical manufacture (sold to IDEX in 2010). Internationally, he serves on the board of a Canadian medical device company (Cellaegis Device, Toronto). He has been a mentor with the Venture Mentoring Service of MIT. He serves on the Board of Overseers of Beth Israel-Deaconess and Newton Wellesley Hospitals. Henry also serves with the Boston Haifa Life Sciences Connection that assists and mentors Haifa based Healthcare companies.

    In addition, he is serving on the boards of Neurofibromatosis (NF Inc.), Mayyim Hayyim and JF&CS, all non profit organizations.

    Henry holds Bachelors (Augusta College) and a Master’s Degrees in Chemistry from Rutgers University, and an MBA in International Marketing from Seton Hall University. Henry is a past President of Temple Beth Elohim in Wellesley, Massachusetts. Henry and his wife Laurie have one grown daughter and reside in Weston, Massachusetts.